We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-13.92%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.18B
AUM Growth
-$341M
Cap. Flow
+$97.4M
Cap. Flow %
4.47%
Top 10 Hldgs %
35.92%
Holding
3,540
New
358
Increased
1,256
Reduced
1,110
Closed
245

Sector Composition

Rank Sector Weight
1 Technology 12.72%
2 Financials 8.76%
3 Healthcare 8.32%
4 Communication Services 4.17%
5 Consumer Discretionary 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOUT icon
2951
American Outdoor Brands
AOUT
$157M
$0 ﹤0.01%
34
-49
-59% -$580
APEI icon
2952
American Public Education
APEI
$940M
-205
Closed -$4K
API
2953
Agora
API
$377M
-12
Closed
AQN icon
2954
Algonquin Power & Utilities
AQN
$4.42B
$0 ﹤0.01%
8
AR icon
2955
Antero Resources
AR
$10.7B
$0 ﹤0.01%
5
+1
+25% +$37
ARCT icon
2956
Arcturus Therapeutics
ARCT
$211M
$0 ﹤0.01%
17
ARKQ icon
2957
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.06B
-242
Closed -$17K
ARKX icon
2958
ARK Space & Defense Innovation ETF
ARKX
$850M
-764
Closed -$14K
ARQT icon
2959
Arcutis Biotherapeutics
ARQT
$3.18B
$0 ﹤0.01%
+7
New +$144
ARRY icon
2960
Array Technologies
ARRY
$855M
$0 ﹤0.01%
32
-76
-70% -$751
ARVN icon
2961
Arvinas
ARVN
$572M
-18
Closed -$1K
ASO icon
2962
Academy Sports + Outdoors
ASO
$2.98B
$0 ﹤0.01%
+9
New +$329
ATAI icon
2963
AtaiBeckley Inc
ATAI
$2.68B
$0 ﹤0.01%
100
ATLC icon
2964
Atlanticus Holdings
ATLC
$1.52B
$0 ﹤0.01%
11
+8
+267% +$321
ATRA icon
2965
Atara Biotherapeutics
ATRA
$76.1M
-8
Closed -$2K
AUB icon
2966
Atlantic Union Bankshares
AUB
$5.97B
-17
Closed -$1K
AUR icon
2967
Aurora
AUR
$13.8B
$0 ﹤0.01%
30
AUTL
2968
Autolus Therapeutics
AUTL
$562M
-982
Closed -$4K
AVA icon
2969
Avista
AVA
$3.24B
-6
Closed
AVO icon
2970
Mission Produce
AVO
$1.17B
-180
Closed -$2K
AVPT icon
2971
AvePoint
AVPT
$2.71B
$0 ﹤0.01%
+46
New +$234
AVTX icon
2972
Avalo Therapeutics
AVTX
$983M
0
AVXL icon
2973
Anavex Life Sciences
AVXL
$310M
-17
Closed
DCH
2974
Dauch Corp
DCH
$1.51B
$0 ﹤0.01%
45
+26
+137% +$196
AZUL
2975
DELISTED
Azul
AZUL
$0 ﹤0.01%
4

Similar funds

Parallel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Parallel Advisors held 3,540 positions worth $2.18B, down 14% from $2.52B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors deployed $97.4M of net new capital in Q2 2022, opening 358 new positions and adding to 1,256 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Value Factor ETF, an estimated $20.7M trimmed.

  • Parallel Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 26,194 shares worth $828K.
  • Parallel Advisors added most to Schwab US Dividend Equity ETF in Q2 2022, an estimated $39.1M increase.
  • Parallel Advisors's biggest Q2 2022 reduction was iShares MSCI USA Value Factor ETF, cutting an estimated $20.7M.
  • Parallel Advisors fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $7.79M.
  • Parallel Advisors's ten largest holdings make up 36% of its $2.18B portfolio in Q2 2022.
  • Parallel Advisors opened 358 new positions and closed 245 in Q2 2022.
  • Parallel Advisors's portfolio value fell 14% quarter-over-quarter to $2.18B.

Based on Parallel Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.